Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148 INR | -3.77% | +3.03% | +6.59% |
Sales 2024 * | 81.13B 972M | Sales 2025 * | 92.97B 1.11B | Capitalization | 203B 2.44B |
---|---|---|---|---|---|
Net income 2024 * | 1.18B 14.12M | Net income 2025 * | 5.06B 60.65M | EV / Sales 2024 * | 2.92 x |
Net Debt 2024 * | 33.7B 404M | Net Debt 2025 * | 27.93B 335M | EV / Sales 2025 * | 2.49 x |
P/E ratio 2024 * |
205
x | P/E ratio 2025 * |
40.2
x | Employees | 6,295 |
Yield 2024 * |
0.13% | Yield 2025 * |
0.33% | Free-Float | 26.56% |
Latest transcript on Piramal Pharma Limited
1 day | -2.80% | ||
1 week | +4.29% | ||
Current month | +4.07% | ||
1 month | +5.73% | ||
3 months | +10.13% | ||
6 months | +27.13% | ||
Current year | +7.67% |
Managers | Title | Age | Since |
---|---|---|---|
Peter DeYoung
CEO | Chief Executive Officer | 46 | 20-03-03 |
Vivek Valsaraj
PSD | President | 51 | 20-06-09 |
Vinay Agrawal
COO | Chief Operating Officer | 60 | 20-04-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 43 | 21-01-03 | |
Neeraj Bharadwaj
BRD | Director/Board Member | 55 | - |
Director/Board Member | 76 | 21-02-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 0 M€ | +4.12% | - | |
0.00% | 0 M€ | +3.22% | - | |
0.00% | 0 M€ | +3.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 148 | -3.77% | 4 128 485 |
24-05-08 | 153.8 | +2.53% | 4,798,100 |
24-05-07 | 150 | -3.85% | 5,867,321 |
24-05-06 | 156 | +3.28% | 26,463,550 |
24-05-03 | 151 | +5.37% | 26,693,210 |
Delayed Quote NSE India S.E., May 09, 2024 at 04:11 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.67% | 2.44B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.75% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- PPLPHARMA Stock